Primers for quantitative real-time PCR analysis
Except for interferon gamma (IFNγ), all primers were from TaqMan Gene expression assays (Applied Biosystems, Foster City, CA, USA): histocompatibility 2, D region locus1 (H2-D1), assay ID Mm01612937_g1; histocompatibility 2, K1 K region (H2-K1), assay ID Mm01612247_mH; beta-2 microglobulin (β2M), assay ID Mm00437764_m1; transporter 1 (TAP1), assay ID Mm00443188_m1; tyrosine hydroxylase (TH), assay ID Mm00447557_m1; neurotransmitter transporter dopamine, assay ID Mm00438388_m1; dopamine receptor D2 (DRD2), assay ID Mm00438545_m1; and glucuronidase beta (GUSB), assay ID Mm01197698_m1. Primers for IFNγ were: 5′-TCAAGTGGCATAGATGTGGAAGAA-3′, 5′-TGGCTCTGCAGGATTTTCATG-3′, and 5′-FAM-ATGCCCCCATGTTTGTGATGGGTGT-3′.
Immunohistochemistry antibodies
The primary antibodies used in immunohistochemistry and their dilutions were: mouse monoclonal antibody against H2D (1:100, 28-14-8; eBioscience, San Diego, CA, USA), mouse monoclonal antibody against major histocompatibility complex class I (MHCΙ) (1:100, OX-18; AbD Serotec, Kidlington, UK), rat monoclonal antibody for MHCΙ (1:100, ER-HR 52;
Abcam, Cambridge, MA, USA), rabbit polyclonal antibody against TH (1:1000, AB152; Millipore, St. Louis, MO, USA), mouse monoclonal antibody against TH (1:1000, MAB318; Millipore), rat monoclonal antibody against glial fibrillary acidic protein (GFAP) (1:1000, 13-0300; Invitrogen, Carlsbad, CA, USA), rabbit polyclonal antibody against ionized calcium-binding adapter molecule 1 (IBA-1) (1/100, 019-1974; Wako, Tokyo, Japan), mouse monoclonal antibody against postsynaptic density protein 95 (PSD-95) (1:500, MAB1596; Millipore), mouse monoclonal antibody against synaptophysin (1:500, MAB329; Millipore), rabbit polyclonal antibody against glutamic acid decarboxylase (GAD)-65/67 (1:100, AB1511; Millipore), and rabbit polyclonal antibody against GFP (1:500, ab6556; Abcam).
Construction of rAAV-2 expressing EGFP or H2D
rAAV-2 encoding EGFP under the TH promoter was constructed as follows. First, EGFP coding sequence was PCR amplified from pEGFP-C1 vector (BD Biosciences, San Jose, CA, USA) using DNA polymerase (pfuTurbo; Stratagene, La Jolla, CA, USA) and the primers, ClaΙ-EGFP Fw and HindΙΙΙ-EGFP Rv. The PCR conditions were: denaturation at 95°C for 2 min, followed by 30 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 1 min, with a final extension cycle at 72°C for 10 min. PCR products were digested with the restriction endonucleases, ClaI and HindIII, and the ~0.7 kb fragment subcloned into the corresponding sites of the pAAV-MCS plasmid (AAV-Helper Free System; Agilent Technologies, Santa Clara, CA, USA) to yield pAAV-CMV-EGFP. The 2.5-kbp TH promoter, which allows specific gene expression in dopaminergic neurons (35, 36) , was PCR amplified from genomic DNA of Sprague-Dawley rats (Japan SLC Inc., Shizuoka, Japan) using DNA polymerase (Phusion; Biolabs, Linden, NJ, USA) and the primers, MluΙ-TH Fw and ClaΙ-TH Rv. The PCR conditions were: denaturation at 98°C for 30 s, followed by 35 cycles of 98°C for 10 s, 65°C for 30 s, and 72°C for 75 s, with a final cycle at 72°C for 5 min. PCR products were excised with the restriction endonucleases, MluΙ and ClaΙ, and subcloned into the corresponding restriction sites of pAAV-CMV-EGFP, replacing the CMV promoter with the TH promoter to yield pAAV-TH-EGFP.
To generate rAAV-2 encoding H2D under the TH promoter, EGFP sequence of pAAV-TH-EGFP was replaced with the ~1.1 kbp H2D sequence. The H2D gene was PCR Nose-pokes and locomotor activity were analyzed against data during the 12-h dark phase on the last day of acquisition (Acq), extinction (Ext), and reinstatement (Reins) periods.
Conditioned stimuli (a brief tone and light illumination) also have reinforcing effects.
Vehicle-administered WT and β2M −/− TAP1 −/− mice showed more active nose-pokes during reinstatement than extinction, consistent with a previous report (13). When criteria were implemented as in our previous work (58) 
